Barclays Raises GE HealthCare (GEHC) PT to $87 Following Q4 Beat, Strong 2026 Outlook

A time earlier that, Stifel expert Rick Wise accrued the firm’s terms people for GE HealthCare to $98 from $95 with a Buy rating. Following the company’s net call, the steadfast expressed encouragement regarding the prudent outlook provided for 2026.

On February 4, Morgan Stanley raised its terms people for GE HealthCare Technologies Inc. (NASDAQ:GEHC) to $85 from $80 with an Equal Weight rating. The steadfast updated its risk-reward appraisal for the banal pursuing Q4 2025 results that surpassed expectations. The steadfast noted that request remains robust, supported by a beardown bid backlog, affirmative adjacent performance, and results from the firm’s infirmary superior expenditure survey.

Copyright: epstock / 123RF Stock Photo

GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and complementary integer solutions utilized successful the diagnosis, treatment, and monitoring of patients successful the US, Canada, and internationally.

While we admit the imaginable of GEHC arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.